• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>African Journal of Pharmacy and Pharmacology >The clinical study of YiShenTongMai decoction in unstable angina complicated with glucose metabolism disorder
【24h】

The clinical study of YiShenTongMai decoction in unstable angina complicated with glucose metabolism disorder

机译：益肾通脉汤加减治疗不稳定型心绞痛合并糖代谢异常的临床研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This study aimed to evaluate the clinical effects of YiShenTongMai decoction working with conventional Western drugs in patients with unstable angina complicated with glucose metabolism disorder. Seventy-six patients with unstable angina complicated with glucose metabolism disorder were randomly divided into two groups: 37 cases were allotted to the control group and were treated with conventional Western medicine; 39 cases were allotted to the experimental group treated with conventional Western medicine and YiShenTongMai decoction (Gold Theragran 20 g, Chinese yam 30 g, Milkvetch root 15 g, Bombyx mori 10 g, Allii macrostemi bulbus 10 g, Cassiac torae 30 g, huai Achyranthis radix 15? g, notoginseng powder 3 g, Pheretima asiatica 15g, Chinese hawthorn 10 g and water 370 ml). The effect of treatment was studied on the indices of electrocardiogram, traditional Chinese medicine (TCM) syndromes, fibrinogen (FIB), C-reactive protein (CRP) levels, standard deviation of Normal-Normal (SDNN), and left ventricular diastolic function (E/A) ratio. There was a significant difference with regards to clinical manifestation improvement in angina control between the experimental group and the control group (94.9% versus 75.7%, P < 0.05), as well as in the electrocardiogram profile (84.6% versus 59.5%, P < 0.05) and syndrome integral (94.9% versus 70.3%, P < 0.05). FIB and CRP decreased while SDNN and E/A increased in both groups but was much higher in the experimental group (P < 0.05). The curative effect of combined YiShenTongMai decoction and Western medicine was better than Western medicine alone in patients with unstable angina complicated with glucose metabolism disorder patients.
机译：本研究旨在评价益肾通脉汤加常规西药治疗不稳定型心绞痛合并葡萄糖代谢异常的临床疗效。 76例不稳定型心绞痛合并葡萄糖代谢异常的患者随机分为两组：37例为对照组，常规西药治疗; 37例为对照组。常规西药加益肾通脉汤（金Theragran 20 g，山药30 g，白v 15 g，家蚕10 g，大葱10 g，C仁30 g，槐木）治疗的实验组39例。基数15克，三七粉3克，亚洲木P 15克，山楂10克，水370毫升。研究了治疗效果对心电图指标，中医（TCM）综合征，纤维蛋白原（FIB），C反应蛋白（CRP）水平，正常-正常（SDNN）和左室舒张功能的影响（ E / A）比率。在实验组和对照组之间，在心绞痛控制方面的临床表现改善方面有显着差异（94.9％比75.7％，P <0.05），以及心电图曲线方面（84.6％比59.5％，P <0.05）。 0.05）和综合症积分（94.9％对70.3％，P <0.05）。两组的FIB和CRP降低，而SDNN和E / A升高，但是实验组的FIB和CRP更高（P <0.05）。益肾通脉汤加西药治疗不稳定型心绞痛合并糖代谢异常患者的疗效优于单药治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号